What did @catts_corner actually say?
The creator, presenting as a clinical practitioner, lists five symptoms she attributes to low testosterone in women: rapid muscle loss despite frequent gym sessions, zero motivation and poor focus, low libido, emotional flatness, and slow workout recovery. She also introduces a term, "Sastron," as if it were a recognized clinical name for testosterone, calling it "anti-catabolic" and important for inflammation control. She frames these as "oddly specific" signs and invites followers to ask questions as part of an ongoing hormone series.
The five symptoms themselves are legitimate clinical territory. The word "Sastron" is not. It does not appear in any pharmacological database, peer-reviewed literature, or recognized drug registry. That is a significant credibility issue buried inside an otherwise reasonable overview.
Does the science back this up?
Mostly yes, with one glaring exception. The symptom cluster she describes, muscle loss, low motivation, reduced libido, emotional blunting, and impaired recovery, does map onto documented presentations of androgen insufficiency in women, though the evidence base is considerably weaker than in men.
On muscle retention: testosterone does have anabolic and anti-catabolic properties in women. A 2019 review by Davis et al. in The Lancet Diabetes and Endocrinology confirmed that androgens contribute to lean mass maintenance in premenopausal and postmenopausal women. On libido: the link between low androgen levels and hypoactive sexual desire disorder (HSDD) in women has the strongest evidence base of any testosterone-related symptom in this population, supported by multiple randomized controlled trials including Shifren et al. (2000, NEJM). On mood and motivation: the data are more mixed. Testosterone has been associated with mood regulation, but causality is harder to establish. Davis and Wahlin-Jacobsen (2019, The Lancet) note the association exists but is not straightforward. Recovery and inflammation: plausible, but direct trial evidence in women is thin.
What did they get wrong (or right)?
They got the symptom list largely right. Muscle loss, libido decline, motivational shifts, and slow recovery are clinically recognized concerns worth discussing in the context of androgen levels in women. Credit where it is due.
What they got wrong is more concerning. "Sastron" is not a real medical term. It is not a brand name, a generic name, or a recognized compound. Using invented or misremembered terminology in a clinical-sounding TikTok series watched by over 20,000 people is not a minor slip. It erodes the accuracy of everything around it and could confuse viewers trying to research their own symptoms or have informed conversations with their doctors.
The framing of these symptoms as "oddly specific" also deserves scrutiny. These five signs overlap substantially with hypothyroidism, depression, perimenopause, overtraining syndrome, and iron deficiency anemia. Presenting them as a neat testosterone checklist without that context is reductive and potentially misleading. Davis et al. (2019, The Lancet Diabetes and Endocrinology) explicitly caution against diagnosing androgen insufficiency by symptoms alone because the overlap with other conditions is too significant.
What should you actually know?
If you see yourself in this symptom list, testosterone is one possible explanation, but it is genuinely not the first thing most endocrinologists would check. Thyroid function, iron stores, cortisol rhythm, and reproductive hormone panels would typically come first. The American College of Obstetricians and Gynecologists does not currently recommend routine testosterone testing for non-specific symptoms in women, and there is no universally agreed-upon "normal" female testosterone range.
Female androgen insufficiency is real, underdiagnosed, and worth taking seriously. But self-diagnosing from a TikTok checklist and then asking a creator for hormone advice in the comments is not a clinical pathway. If these symptoms resonate with your experience, a blood panel with a hormone-literate provider is the appropriate next step, not a comment section.
One more thing: "Sastron" does not exist as a named drug or compound in any jurisdiction. If you see it referenced as something to take or ask your doctor about, treat that as a red flag for the reliability of the source overall.